Pascal and Francis Bibliographic Databases


Search results

Your search

au.\*:("PUTNEY S")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 47

  • Page / 2

Selection :

  • and

How antibodies block HIV infection : paths to an AIDS vaccinePUTNEY, S.Trends in biochemical sciences (Amsterdam. Reference ed.). 1992, Vol 17, Num 5, pp 191-196, issn 0376-5067Article


A unidirectional deletion technique for the generation of clones for sequencingOZKAYNAK, E; PUTNEY, S. D.BioTechniques. 1987, Vol 5, Num 8, pp 770-773, issn 0736-6205Article

Human immunodeficiency virus type 1 entry into T cells : more-rapid escape from an anti-V3 loop than from an antireceptor antibodyLU, S; PUTNEY, S. D; ROBINSON, H. L et al.Journal of virology. 1992, Vol 66, Num 4, pp 2547-2550, issn 0022-538XArticle

Antigenic variation in HIVPUTNEY, S. D; MCKEATING, J. A.AIDS (London). 1990, Vol 4, pp S129-S136, issn 0269-9370, SUPConference Paper

Isolation of a functional human gene for brain creatine kinaseDAOUK, G. H; KADDURAH-DAOUK, R; PUTNEY, S et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 5, pp 2442-2446, issn 0021-9258Article

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMsTAKAHASHI, H; TAKESHITA, T; MOREIN, B et al.Nature (London). 1990, Vol 344, Num 6269, pp 873-875, issn 0028-0836, 3 p.Article

Improving protein therapeutics with sustained-release formulationsPUTNEY, S. D; BURKE, P. A.Nature biotechnology. 1998, Vol 16, Num 2, pp 153-157, issn 1087-0156Article

Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation developmentCLELAND, J. L; JOHNSON, O. L; PUTNEY, S et al.Advanced drug delivery reviews. 1997, Vol 28, Num 1, pp 71-84, issn 0169-409XArticle

Epitopes recognized by the neutralizing antibodies of an HIV-1-infected individualPROFY, A. T; SALINAS, P. A; ECKLER, L. I et al.The Journal of immunology (1950). 1990, Vol 144, Num 12, pp 4641-4647, issn 0022-1767Article

Proliferative T-cell response to HIV envelope glycoprotein in immunized and infected primates and human beingsKROHN, K; RANKI, A; LUSSO, P et al.Journal of medical primatology. 1989, Vol 18, Num 3-4, pp 363-369, issn 0047-2565, 7 p.Article

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitopeMATSUSHITA, S; ROBERT-GUROFF, M; RUSCHE, J et al.Journal of virology. 1988, Vol 62, Num 6, pp 2107-2114, issn 0022-538XArticle

Production and characterization of fusion proteins containing transferrin and nerve growth factorPARK, E; STARZYK, R. M; MCGRATH, J. P et al.Journal of drug targeting. 1998, Vol 6, Num 1, pp 53-64, issn 1061-186XArticle

B and T cell reactivities after immunization of macaques with HIV subcomponentsWAHREN, B; CHIODI, F; LJUNGGREN, K et al.AIDS research and human retroviruses. 1988, Vol 4, Num 3, pp 199-210, issn 0889-2229Article

The rabbit muscle phosphofructokinase gene: implications for protein structure, function, and tissue specificityCHAN-PING LEE; MING-CHING KAO; FRENCH, B. A et al.The Journal of biological chemistry (Print). 1987, Vol 262, Num 9, pp 4195-4199, issn 0021-9258Article

The complete nulceotide sequence for rabbit muscle aldolase A messenger RNATOLAN, D. R; AMSDEN, A. B; PUTNEY, S. D et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 2, pp 1127-1131, issn 0021-9258Article

A large-scale process to produce microencapsulated proteinsHERBERT, P; MURPHY, K; JOHNSON, O et al.Pharmaceutical research. 1998, Vol 15, Num 2, pp 357-361, issn 0724-8741Article

Synthetic peptide derived from the Bordetella pertussis bacterium reduces infarct volume after transient middle cerebral artery occlusion in the ratZHANG, R. L; CHOPP, M; TANG, W. X et al.Neurology. 1996, Vol 46, Num 5, pp 1437-1441, issn 0028-3878Article

Structural requirements for class I MHC molecule-mediated antigen presentation and cytotoxic T cell recognition of an immunodominant determinant of the human immunodeficiency virus envelope proteinTAKAHASHI, H; HOUGHTEN, R; PUTNEY, S. D et al.The Journal of experimental medicine. 1989, Vol 170, Num 6, pp 2023-2035, issn 0022-1007Article

Cerebral cell adhesion molecule : A novel leukocyte adhesion determinant on blood-brain barrier capillary endotheliumSTARZYK, R. M; ROSENOW, C; FRYE, J et al.The Journal of infectious diseases. 2000, Vol 181, Num 1, pp 181-187, issn 0022-1899Article

Construction of peptides encompassing multideterminant clusters of human immunodeficiency virus envelope to induce in vitro T cell responses in mice and humans of multiple MHC typesBERZOFSKY, J. A; PENDLETON, C. D; CLERICI, M et al.The Journal of clinical investigation. 1991, Vol 88, Num 3, pp 876-884, issn 0021-9738Article

Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strainSCOTT, C. F; SILVER, S; PROFY, A. T et al.Proceedings of the National Academy of Sciences of the United States of America. 1990, Vol 87, Num 21, pp 8597-8601, issn 0027-8424, 5 p.Article

Type-restricted neutralization of molecular clones of human immunodeficiency virusLOONEY, D. J; FISHER, A. G; PUTNEY, S. D et al.Science (Washington, D.C.). 1988, Vol 241, Num 4863, pp 357-359, issn 0036-8075Article

Peptide from a prokaryotic adhesin blocks leukocyte migration in vitro and in vivoROZDZINSKI, E; SPELLERBERG, B; VAN DER FLIER, M et al.The Journal of infectious diseases. 1995, Vol 172, Num 3, pp 785-793, issn 0022-1899Article

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1- abolishes infectivity for chimpanzeesEMINI, E. A; NARA, P. L; GERETY, R. J et al.Journal of virology. 1990, Vol 64, Num 8, pp 3674-3678, issn 0022-538X, 5 p.Article

  • Page / 2